Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1971 1
1973 1
1975 1
1976 1
1977 1
1981 1
1982 1
1983 2
1984 2
1987 2
1989 1
1993 2
1994 1
1995 5
1996 1
1998 3
1999 6
2000 1
2001 6
2002 4
2003 5
2004 1
2005 6
2006 5
2007 3
2008 5
2009 2
2010 8
2011 6
2012 4
2013 9
2014 13
2015 5
2016 9
2017 9
2018 8
2019 8
2020 3
2021 7
2022 9
2023 7
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

158 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Lung Synovial Sarcoma"
Page 1
Popliteal Fossa Sarcomas.
Erdogan O, Çeli K A, Yildirim ANT, Tekçe E, Altun G, Demi Röz S, Güler Y, Ozkan K, Gurkan V. Erdogan O, et al. Acta Chir Orthop Traumatol Cech. 2023;90(3):181-187. Acta Chir Orthop Traumatol Cech. 2023. PMID: 37395425 English.
The mean follow-up was 41.79 16.97 (range 24-120) months. The most common histological diagnoses were synovial sarcoma (6 patients), hemangiopericytoma (2 patients), soft tissue osteosarcoma (2 patients), unidentified fusiform cell sarcoma (2 patients), and m …
The mean follow-up was 41.79 16.97 (range 24-120) months. The most common histological diagnoses were synovial sarcoma (6 pati …
Pleural neoplastic pathology.
Karpathiou G, Stefanou D, Froudarakis ME. Karpathiou G, et al. Respir Med. 2015 Aug;109(8):931-43. doi: 10.1016/j.rmed.2015.05.014. Epub 2015 May 21. Respir Med. 2015. PMID: 26048082 Free article. Review.
RESULTS: Malignant pleural mesothelioma (MPM) is the commonest primary pleural epithelial tumor showing remarkable histological heterogeneity often with prognostic significance. Various genetic alterations like changes in INK4 locus, NF2, BAP1 but also epigenetic changes a …
RESULTS: Malignant pleural mesothelioma (MPM) is the commonest primary pleural epithelial tumor showing remarkable histological heterogeneit …
BCOR-CCNB3 Fusion Positive Sarcomas: A Clinicopathologic and Molecular Analysis of 36 Cases With Comparison to Morphologic Spectrum and Clinical Behavior of Other Round Cell Sarcomas.
Kao YC, Owosho AA, Sung YS, Zhang L, Fujisawa Y, Lee JC, Wexler L, Argani P, Swanson D, Dickson BC, Fletcher CDM, Antonescu CR. Kao YC, et al. Am J Surg Pathol. 2018 May;42(5):604-615. doi: 10.1097/PAS.0000000000000965. Am J Surg Pathol. 2018. PMID: 29300189 Free PMC article.
BCOR-CCNB3 sarcoma (BCS) is a recently defined genetic entity among undifferentiated round cell sarcomas, which was initially classified as and treated similarly to the Ewing sarcoma (ES) family of tumors. ...Local recurrences occurred in 6 patients and distant meta …
BCOR-CCNB3 sarcoma (BCS) is a recently defined genetic entity among undifferentiated round cell sarcomas, which was initially classif …
Sarcoma of unknown primary: myth or reality?
Rassy E, Abou-Jaoude R, Boussios S, Assi T, Kattan J, Khaled H, Pavlidis N. Rassy E, et al. J Egypt Natl Canc Inst. 2022 Jun 27;34(1):27. doi: 10.1186/s43046-022-00128-1. J Egypt Natl Canc Inst. 2022. PMID: 35754068 Review.
BACKGROUND: Sarcoma of unknown primary (SUP) designates an enigmatic entity with histologic confirmation of a metastatic tumor without an identifiable primary after a thorough diagnostic workup. ...We excluded articles reporting on cases with sarcomas from known organ site …
BACKGROUND: Sarcoma of unknown primary (SUP) designates an enigmatic entity with histologic confirmation of a metastatic tumor withou …
Epithelioid sarcoma of Enzinger.
Fisher C. Fisher C. Adv Anat Pathol. 2006 May;13(3):114-21. doi: 10.1097/00125480-200605000-00002. Adv Anat Pathol. 2006. PMID: 16778474 Review.
The tumor has no normal cellular counterpart and differs from both synovial sarcoma and carcinoma. There is a wide differential diagnosis from numerous benign and malignant conditions, including granuloma annulare, melanoma, and epithelioid vascular neoplasms. Epith …
The tumor has no normal cellular counterpart and differs from both synovial sarcoma and carcinoma. There is a wide differentia …
Feasibility and long-term outcomes of surgery for primary thoracic synovial sarcoma.
Pieropan S, Mercier O, Mitilian D, Pradère P, Fabre D, Ion DI, Mir O, Galbardi B, Thomas De Montpreville V, Fadel E. Pieropan S, et al. Interact Cardiovasc Thorac Surg. 2022 Sep 9;35(4):ivac238. doi: 10.1093/icvts/ivac238. Interact Cardiovasc Thorac Surg. 2022. PMID: 36066443 Free PMC article.
OBJECTIVES: Primary thoracic synovial sarcoma (SS) is a rare, high-grade, malignancy. Involvement of vital organs is frequent and may decrease the benefits of surgical resection. ...By univariate analysis, incomplete resection was the only significant predictor …
OBJECTIVES: Primary thoracic synovial sarcoma (SS) is a rare, high-grade, malignancy. Involvement of vital organs is frequent …
Primary synovial sarcoma of bone: a retrospective analysis of 25 patients.
Righi A, Gambarotti M, Benini S, Gibertoni D, Asioli S, Magagnoli G, Gamberi G, Sbaraglia M, Cocchi S, Staals E, Palmerini E, Dei Tos AP. Righi A, et al. Histopathology. 2022 Mar;80(4):686-697. doi: 10.1111/his.14602. Epub 2022 Jan 18. Histopathology. 2022. PMID: 34821406
AIMS: To evaluate the diagnostic accuracy of SSX and SSX::SS18 antibodies in decalcified surgical specimens and outcome of synovial sarcomas (SS) of bone. METHODS AND RESULTS: Twenty-five cases were classified as bone SS (prevalence 0.32% among malignant primary bone sa …
AIMS: To evaluate the diagnostic accuracy of SSX and SSX::SS18 antibodies in decalcified surgical specimens and outcome of synovial s …
Predictors of lung recurrence and disease-specific mortality after pulmonary metastasectomy for soft tissue sarcoma.
Tetta C, Rocca M, Salone M, Longhi A, Ferrari C, Londero F, Parise G, Parise O, Giugliano A, Maessen JG, La Meir M, Gelsomino S. Tetta C, et al. Surg Oncol. 2021 Jun;37:101532. doi: 10.1016/j.suronc.2021.101532. Epub 2021 Feb 20. Surg Oncol. 2021. PMID: 33639455
METHODS: From June 1988 to July 2019, 164 patients were referred to Rizzoli Orthopedic Hospital, Bologna, Italy) for STS lung metastasectomy (LMTS). The endpoints were lung metastasis recurrence (LMR) and lung metastasis-specific mortality (LMSM). ...The mali …
METHODS: From June 1988 to July 2019, 164 patients were referred to Rizzoli Orthopedic Hospital, Bologna, Italy) for STS lung metasta …
Histology and grading are important prognostic factors in synovial sarcoma.
Bianchi G, Sambri A, Righi A, Dei Tos AP, Picci P, Donati D. Bianchi G, et al. Eur J Surg Oncol. 2017 Sep;43(9):1733-1739. doi: 10.1016/j.ejso.2017.05.020. Epub 2017 May 25. Eur J Surg Oncol. 2017. PMID: 28579008
INTRODUCTION: The diagnosis of synovial sarcoma (SS) is currently based on clinical, morphological, immunohistochemical and cytogenetic data. ...Prognosis was worse in those patients monophasic SS (p = 0.011) as in those with a grade 3 tumors (p = 0.083). ...
INTRODUCTION: The diagnosis of synovial sarcoma (SS) is currently based on clinical, morphological, immunohistochemical and cy …
Primary synovial sarcoma of the lung: a rare presentation, diagnostic dilemma and review of literature.
Pandey L, Joseph D, Pasricha R, Gupta MK. Pandey L, et al. BMJ Case Rep. 2020 Nov 23;13(11):e237678. doi: 10.1136/bcr-2020-237678. BMJ Case Rep. 2020. PMID: 33229486 Free PMC article. Review.
Primary synovial sarcoma of the lung (PSSL) is a rare tumour with only 0.5% incidence among other primary malignant lung tumours. Published medical literature regarding the natural history treatment protocol and clinical outcomes of PSSL remains limite …
Primary synovial sarcoma of the lung (PSSL) is a rare tumour with only 0.5% incidence among other primary malignant …
158 results